375348-49-5

Usage

Uses

Used in Allergy and Autoimmune Response Management:
Bertilimumab is used as an immunomodulatory agent for managing allergic and autoimmune responses by reducing eosinophil-mediated inflammation. This makes it a potential treatment for conditions characterized by eosinophilic inflammation, such as asthma, atopic dermatitis, and inflammatory bowel disease.
Used in Asthma Treatment:
In the field of respiratory medicine, bertilimumab is used as a therapeutic agent for treating severe asthma, particularly in patients with elevated eosinophil levels. It helps in reducing asthma exacerbations and improving lung function by targeting the eosinophilic inflammation that contributes to the disease's severity.
Used in Atopic Dermatitis Treatment:
In dermatology, bertilimumab is used as a treatment for atopic dermatitis, an inflammatory skin condition. By inhibiting eotaxin-1, it reduces eosinophil infiltration into the skin, which can help alleviate symptoms such as itching, redness, and swelling.
Used in Inflammatory Bowel Disease Treatment:
In gastroenterology, bertilimumab is used as a potential treatment for inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis. It targets the eosinophilic inflammation that plays a role in the pathogenesis of these conditions, potentially leading to a reduction in disease activity and improvement in patient outcomes.